Pfizer-BioNTech seek EU emergency approval for Covid-19 vaccine, target Dec rollout

      Published on Thursday, 3 December , 2020      1690 Views     
Pfizer-BioNTech seek EU emergency approval for Covid-19 vaccine, target Dec rollout


Pfizer Inc and BioNTech’s Covid-19 vaccine could be rolled out in Europe this month, the companies said on Tuesday after they applied for EU emergency approval for the shot.

The application to the European Medicines Agency (EMA) comes days after the companies applied for emergency use of their vaccine in the United States. They said their candidate, BNT162b2, could be launched in the European Union this month.





‘If EMA concludes that the benefits of the vaccine candidate outweigh its risks in protecting against Covid-19, it will recommend granting a CMA (conditional marketing authorization)that could potentially enable use of BNT162b2 in Europe before the end of 2020,’ they said in a joint statement.

In their pursuit of a European launch, the partners are neck-and-neck with rival Moderna, which said on Monday it would ask the EU regulator to recommend conditional approval for its shot.

An effective immunization is seen as the main weapon against the pandemic, which has claimed more than 1.4 million lives and ravaged economies across the globe. Close to 50 potential vaccines are being tested on volunteers worldwide.

US drugmaker Pfizer and Germany’s BioNTech reported final trial results on Nov. 18 that showed their vaccine candidate was 95% effective in preventing Covid-19, with no major safety concerns, raising the prospect of US and European approval as early as December.

Any clearance in the EU and United States will be ‘conditional’ or for ‘emergency use’, respectively, meaning developers are obliged to continue trials and provide more trial results as they emerge.

The European filing completes the so-called rolling review process, which was initiated with the EMA on Oct. 6.



The British government said last week that Pfizer and BioNTech had reported the data from their clinical trials to the Medicines and Healthcare products Regulatory Agency (MHRA).


Keywords:
Category Doha News, World | 2020/12/03 latest update at 10:50 PM
Source : Mena FN | Photocredit : Google
1691 Views
Comments Add comment



Gulf Media

Related Articles

The editorial staff of Qatar Today would like to give all of its readers from Gulf and Qatar and the whole world the opportunity to participate actively in the development of the website! If you have something interesting, fun, scandalous - just something worth to be seen from more people. Capture it and share it in the Qatar Today with a short text.

Do you have information you want to reach our readers?

Send article/s

You can subscribe to our Facebook, Twitter and Google pages or use our RSS feed channel to always read the most important news about Qatar, the Gulf and the world.